https://orcid.org/0000-0002-2233-9270
References
- Ludwig J, Hashimoto E, McGill DB, van Heerden JA. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc. 1990;65:51–55. doi:10.1016/S0025-6196(12)62109-0
- Valla DC. Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome. Gut. 2008;57:1469. doi:10.1136/gut.2007.133637
- Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. EN-Vie (European Network for Vascular Disorders of the Liver). Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009;151(3):167–175. PMID: 19652186. doi:10.7326/0003-4819-151-3-200908040-00004
- Grover S, Rastogi A, Singh J, Rajbongshi A, Bihari C. Spectrum of histomorphologic findings in liver in patients with SLE: a review. Hepat Res Treat. 2014;2014:562979. PMID: 25136456; PMCID: PMC4130189. doi:10.1155/2014/562979
- Hallegua DS, Venuturupalli S. Gastrointestinal and hepatic manifestations. In: Wallace DJ, Hahn BH, editors. Dubois’ Lupus Erythematosus and Related Syndromes. Vol. 8. Philadelphia: Elsevier Saunders; 2013:420.
- Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009;151:167. doi:10.7326/0003-4819-151-3-200908040-00004
- Zuily S, Regnault V, Guillemin F, et al. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study. Thromb Res. 2013;132:e1. doi:10.1016/j.thromres.2013.04.012
- Cervera R, Serrano R, Pons-Estel GJ, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015;74:1011. doi:10.1136/annrheumdis-2013-204838
- Danowski A, de Azevedo MN, de Souza Papi JA, Petri M. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol. 2009;36(6):1195–1199. PMID: 19447935. doi:10.3899/jrheum.081194
- Espinosa G, Font J, García-Pagan JC, et al. Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine. 2001;80(6):345–354. doi:10.1097/00005792-200111000-00001
- Ilkgül O, Içöz G, Dayangaç M, Tokat Y, Ozütemiz O. A case of antiphospholipid antibody syndrome with Budd-Chiari and colonic ulcers complicated with gastrointestinal hemorrhage. Turk. J Gastroenterol Off J Turk Soc Gastroenterol. 2004;15(2):115–116.
- Seijo S, Plessier A, Hoekstra J, et al. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 2013;57:1962–1968. doi:10.1002/hep.26306
- Shukla A, Shreshtha A, Mukund A, et al. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2021;15:531–567. doi:10.1007/s12072-021-10189-4
- Pandiaraja J, Sathyaseelan A. Budd- Chiari syndrome as an initial manifestation of systemic lupus erythematosus. J Clin Diagn Res. 2016;10(4):OD01–2. PMID: 27190864; PMCID: PMC4866162. doi:10.7860/JCDR/2016/16623.7532
- Rhee J, Demetris AJ, Abu Elmagd K, Rabinovitz M. Suprahepatic Budd Chiari syndrome treated with thrombectomy and cavoplasty. Dig Dis Sci. 2003;48(8):1637–1641. doi:10.1023/A:1024740512762